Residency Program Doctor of Medicine (MD) Curriculum (Phase-B) PULMONOLOGY

1. Introduction:

1.1. Overview of the Speciality

The speciality of Pulmonology developed as a sub-specialization of

physicians who are predominantly concerns with the care of patients

with respiratory disorders. It is a branch of internal medicine

concerned with prevention intervention, investigation and therapy and

research into diseases involving the respiratory system. Care of

patients with respiratory disorders embraces a wide range of clinical

activities and respiratory physicians need a broad view of the

respiratory needs of individual patients and the communities in which

they live including an understanding of any prevailing healthcare

inequalities. This requires knowledge of not only the diagnostic and

therapeutic modalities available, but also an appreciation of the

importance of the epidemiology and potential for prevention of

respiratory diseases.

Although pulmonology is generally stereotyped and highly practical

skill based medical speciality, with invasive and interventional skills as

high-profile components of the workload, competence in other areas of

practice such as respiratory clinical pharmacology and respiratory

imaging are equally important. Indeed the expert clinical management

of patients with respiratory failure, pulmonary. hypertension, use of

Non-Invasive Ventilation (NIV) as rewarding as the quasi surgical skills

demanded of the pulmonary interventionist. Respiratory physicians

generally work as hospital based specialists and need to integrate their

work with not only community based primary care colleagues but also

other hospital based physicians. e.g. critical care specialist, ENT

surgeons, as well as working closely with Thoracic surgeons and

anesthesiologists and the imaging specialties, e.g. radiology and

nuclear medicine. Sub-specialization within Pulmonology has become

common place with individuals focusing the development of their

expertise in areas such as pulmonary intervention, Sleep medicine

specialist, respiratory failure and pulmonary hypertension.


1.2. Pulmonology Residency Program

Residents will undertake a three year intensive Phase B training after

completion of Phase A training in order to achieve the levels of

knowledge, skills and expertise required for clinical practice in the field

of respiratory medicine. It is a competency-based program

emphasizing on meaningful integration and contex- tualization. The

two years phase A training program is designed to introduce and

develop the broad range of core knowledge, skills, attitudes and

behaviours required to become a competent physician. The

knowledge and skills acquired during Phase A training are further

focused and refined during Phase B training, which is a 3 year

speciality-specific training in Pulmonology.

The teaching, learning and assessment of the curriculum is facilitated

by the provision of comprehensive, educationally oriented supervision

and support, which is provided to all trainees across both the phases

of the program.

2. Goals and objectives:

2.1. Overall Goals

1. To prepare respiratory physicians who would be able to meet

and respond to the changing healthcare needs and

expectation of the society.

2. To develop respiratory physicians who posses knowledge,

skills and attitudes that will ensure that they are competent to

practice respiratory medicine, safely and effectively.

3. To ensure that they have appropriate foundation for lifelong

learning and further training in their speciality.

4. To help them develop to be critical thinkers and problem

solvers when managing health problems in the community

they serve.

2.2. General Objectives:

The educational and training process aims to produce respiratory

physicians who:-

• Can address all aspects of the healthcare needs of patients

and their families

• Maintain the highest standards appropriate in their

professional field


• Are aware of current thinking about ethical and legal issues

• Are able to act as safe independent practitioners whilst

recognizing the limitation of their own expertise and are able

to recognize their obligation to seek assistance of colleagues

where appropriate

• Are aware of the procedures, and able to take appropriate

action, when things go wrong, both in their own practice and

in that of others

• Will be honest and objective when assessing the performance

of those they have supervised and trained

• Can take advantage of information technology• to enhance all

aspects of patient care

• Can develop management plans for the "Whole patient" and

maintain a knowledge in other areas of medicine which

impinge on the speciality of Pulmonology.

• Understand that more effective communication between them

and their patients can lead to more effective treatment and

care

• Apply appropriate knowledge and skill in the diagnosis and

management of patients

• Establish a differential diagnosis for patients presenting with

medical problems by the appropriate use of the clinical

history, examination and investigations

• Are competent to perform the core investigations and

procedures required in their specialties.

• Develop clinical practice which is based on an analysis of

relevant clinical trials and to have an understanding of their

research methodologies

• Are able to apply the knowledge of biological and behavioral

sciences in clinical practice

• Are able to identify and take responsibility for their own

educational needs and the attainment of these needs

• Have developed the skills of an effective teacher

3. Admission Requirements for Phase B Training:

A. Residents who has successfully completed Phase A training

and passed Phase A Final Examination are eligible for

enrolment in the Phase B program.


B. Candidates with FCPS/MD in Internal Medicine can be

enrolled directly into Phase- B of the residency program

4. Phase B Curriculum structure:

The training is designed to develop both the generic and

speciality-specific attributes necessary to practice independently as a

consultant respiratory physicians. The aim is to train individuals to

provide the highest standard of service to patients with respiratory

disorders. This includes the development of positive attitudes towards

lifelong learning and the ability to adopt to future technological

advances and the changing expectations of society.

4.1. Phase B: Pulmonology Speciality Training:

In-depth speciality-specific educational and training program in this

phase will make the resident competent and prepare them for the

speciality qualification. It will provide educational program covering

the speciality of Respiratory Medicine and its subspecialties,

Biostatistics, Research Methodology and Medical Education along

with rotation specific clinical training.

4.2. Expected outcome sat the completion of the Phase B Program:

Resident of this training program will be equipped to function

effectively within the current and emerging professional, medical and

social contexts. At the completion of the training program in

Pulmonology, as defined by this curriculum, it is expected that a new

Respiratory specialist will have developed the clinical skills and have

acquired the theoretical knowledge for competent practice in the field

of Pulmonology. It is expected that a new Respiratory specialist will be

able to

• Utilize effective communication with patients and their families

and with professional colleagues

• Be devoted to life long learning

• Be equipped to manage both acute and chronic respiratory

diseases

• Identify the path of physiology and manifestations of

respiratory diseases and modern therapeutics, which can be

applied to patient diagnosis and management

• Apply appropriate skills to perform necessary diagnostic and

therapeutic decisions


• Demonstrate a capacity to rationally analyze clinical data and

published work

• Demonstrate an understanding of and commitment to the role

of research in advancing medical care of respiratory disease

• Develop a commitment to compassionate, ethical professional

behavior

• Identity respiratory medicine related health issues of

importance to the community and contribute constructively to

debate about those issues

• Apply primary and secondary prevention strategies in

respiratory disease

5. Teaching and Learning Methods:

The bulk of learning occurs as a result of clinical experiences

(experiential learning, on-the-job learning) and self-directed study.

The degree of self-directed learning will increase as trainees became

moral experienced. teaching and learning occurs using several

methods that range from formal didactic lectures to planned clinical

experiences Aspects covered will include knowledge, skills and

practices relevant to the discipline ifl order to achieve specific learning

outcomes and competencies. The theoretical part of the curriculum

presents the current body of knowledge necessary for practice. This

can be imparted using lectures, grand teaching rounds,

clinico-pathological meetings, morbidity/mortality review meetings,

literature reviews and presentations, journal clubs, self-directed

learning, conferences and seminars.

6. Record of Training:

The evidence requires confirming progress through training includes:

• Details of the training rotations, the training plan agreed with

weekly timetables and duty rosters; and numbers of practical

procedures and outcomes

• Confirmations of attendance at events in the educational

program, at departmental and inter-departmental meetings

and other educational events.

• Confirmation (certificates) of attendance at subject based/

skills- training/ instructional courses


• A properly completed logbook with entries capable of

testifying to the training objectives which have been attained

and the standard of performance achieved.

• CME activity

• Supervisor's report on Observed performance (in the

workplace): of duties, practical procedures of presentations

made and teaching activity; of advising and working with

others, of standards of case notes, correspondence and

communication with others.

6.1. Logbook:

Residents are requested to maintain a Logbook in which entries of

academic/ professional work done during the period of training should

be made on daily basis and signed by the supervisor completed and

duly certified logbook will form a part of the application for appearing

in Phase B Final examinations.

7. Research:

Development of research competencies forms an important part of the

Residency program curriculum as they are an essential set of skills for

effective clinical practice undertaking research helps to develop

critical thinking and the ability to review medical literature. Every

Resident shall carry out work on an assigned research project under

the guidance of a recognized supervisor; the project shall be written

and submitted in the form of a Thesis/Research Report.

8. Assessment:

The assessment for certification of the MD degree of the University is

comprehensive, integrated and phase-centered attempting to identify

attributes expected of specialists for independent practice and lifelong

learning and covers cognitive, psychomotor and affective domains. It

keeps strict reference to the components, the contents, the

competencies and the criteria laid down in the curriculum.

Assessment includes both Formative Assessment and Summative

(Phase final) Examinations.

8.1.1. End of Block Assessment (EBA):

End of Block Assessment (EBA) is a periodic formative assessment

and is undertaken after completion of each training block, assessing

knowledge, skills and attitude of the residents. Components of EBA

are written examination, structured clinical Assessment (SCA),

medical record review, and logbook assessment. Unsatisfactory block


training must be satisfactorily completed to be eligible for phase final

examination

8.1. Formative Assessment:

Formative assessment will be conducted throughout the training

phases. It will be carried out for tracking the progress of residents,

providing feedback, and preparing them for final assessment (Phase

completion exams).

There will be Continuous (day-to-day) and Periodic type of formative

assessment.

• Continuous (day-to-day) formative assessment in classroom

and workplace settings provides guide to a resident's learning

and a faculty's teaching / learning strategies to ensure

formative lesson / training outcomes.

• Periodic formative assessment is quasi-formal and is directed

to assessing the outcome of a block placement or academic

module completion. It is held at the end of Block Placement

and Academic Module Completion. The contents of such

examinations include Block Units of the Training Curriculum

and Academic Module Units of the Academic Curriculum.

8.1.2. Formative assessment for Academic modules for

Biostatics and Research Methodology and Medical

Education to be done in the first nine months of Phase

B training. Residents getting unsatisfactory grade must

achieve satisfactory grade by appearing the

re-evaluation examination to be eligible for the Phase B

Final Examination.

8.2. Summative Examination:

Assessment will be done in two broad compartments.

a) Compartment A: Consist of 3 (three) components.

1. Written Examination (Consists of 2 papers).

2. Clinical Examination (One long and four short cases).

3. SCA and Oral (10 stations SCA. Oral one board

consisting of 2 examiners).

Every Resident must pass all the 3 components of compartment-A

separately. Candidates will be declared failed if he/she fails in one or


more component (s) of the examination. He/she then have to appear

all the 3 components in the next Phase B Final Examination.

b) Compartment B: Thesis and Thesis defense.

8.2.1. Written Examination:

Two Papers: Contents of written papers listed in Annexure II

Question type and marks:

• Two Papers (Paper I and Paper II); 100 marks each;

Time 3 hrs for each paper. Pass marks-60% of total of

2 papers.

• Each paper will consist of Two Groups:

• Group A:

- 10 short questions (5 marks each)

- These will assess the knowledge of different level

and its application

• Group B:

- 5 scenario based problem solving questions

(10 marks for each).

- The questions should focus to assess the capability

of handling clinical problem independently and

comprehensively as a specialist.

- Suggested format:-

- A scenario followed by question(s).

- Questions may include diagnosis, differential

diagnosis, investigation plan, treatment, follow up

and patient education.

8.2.2. Clinical Examination: Long case and Short case:

• There will be one long case and four short cases.

i) Long case: Marks-100

- Directly observed

- Two examiners for each examinee.

- History taking and examination by the examinee - 30min.

- Discussion on the case 20 min.(presentation 6min,

crossing 6x2min and decision 2min).


- Examiners will not ask any question nor stop the

examinee in any way during history taking and

physical examinations.

- Discussion should be done preferably as per

structured format and proper weightage on different

segments of clinical skills.

II. Short cases : Marks-100

- Four in number

- Time 20-30 min. (Time will be equally divided for

each short case)

- Crossing should be done with proper weightage on

different segment of clinical skills.

II. Pass marks: 60% of total of Long and Short Cases

8.2.3. Structured Clinical Assessment (SCA): Marks-100

• 10 stations: 5 min each

8.2.4. Oral Examination: Marks-100

- One board consisting of 2 examiners.

- 20 minutes (9+9+2).

8.2.5. Pass marks in SCA and Oral: 60% of total (SCA and Oral.)

8.3. Thesis Evaluation:

• Marks: Thesis writing-200; Defense-100: Marks for

acceptane-60% of total.

- To be evaluated by 3 (three) evaluators:- 2 subject

specialists and one academician preferably involve in

research and teaching research methodology.

- Among the subject specialists one should be external.

- Evaluators should be in the rank of Professor/Associate/

Professor.

- Supervisor will attend the defense as an observer and

may interact only when requested by the evaluators.

- Thesis must be submitted to the controller of Exam not

later than 27 months of enrolment in Phase-B. I Thesis

must be sent to the evaluators 2 (Two) weeks prior to

assessment date.


- Evaluation will cover Thesis writing and its defense.

- For thesis writing evaluator will mark on its structure,

content, flow, scientific value, cohesion, etc.

- For defense - Candidate is expected to defend, justify and

relate the work and its findings.

- Assessment must be completed in next 3 months.

- Outcome of the assessment shall be in 4 categories -

"Accepted", "Accepted with minor correction", "Accepted

with major correction" and "Not Accepted".

8.3.1. Description of terms:

• Accepted: Assessors will sign the document and resident will

bound it and submit to the Controller of Examinations by 10

days of the examination.

• Accepted with minor correction: Minor correction shall

include small inclusion/exclusion of section; identified missing

references, correction of references and typographical and

language problem. This should be corrected and submitted

within 2 weeks.

• Accepted with major correction: Task is completed as) per

protocol with acceptable method but some re-analysis of

result and corresponding discussion are to be modified.)

To be corrected, confirmed by Supervisor and submit within 3

(Three) weeks.

• Not Accepted: When work is not done as per protocol or

method was faulty or require further inclusion or confirmation

of study.

- To complete the suggested deficiencies and reappear in

defense examination during its next Phase Final

Examination.

- Candidate has to submit his/her thesis and sit for

examination and pay usual examination fees for the

examination.

8.3.2. Residents must submit and appear Thesis defense at notified

date and time. However non- acceptance of the Thesis does

not bar the resident in appearing the written, clinical and oral

exam.


8.4. Qualifying for MD Degree:

On passing both the compartments, the candidate will be conferred

the degree of MD in the respective discipline. If any candidate fails in

one compartment he/she will appear in that compartment only in the

subsequent Phase-B exam.

9. Supervision and Training Monitoring:

Training should incorporate the principle of gradually increasing

responsibility, and provide each trainee with a sufficient scope, volume

and variety of experience in a range of settings that include inpatients.

outpatients, emergency and intensive care. All elements of work in

training rotation must be supervised with the level of supervision

varying depending on the experience of the trainee and the clinical

exposure. Outpatient and referral supervision must routinely include the

opportunity to personally discuss ail cases. As training progresses the

trainee should have the opportunity for increasing autonomy, consistent

with safe and effective care for the patient. Trainees will at all times

have a named Supervisor, responsible for overseeing their education.

Supervisors are responsible for supervision of learning throughout

the program to ensure patient and I or laboratory safety, service

delivery as well as the progress of the resident with learning and

performance. They set the lesson plans based on the curriculum.

undertake appraisal, progress against the curriculum, give feedback

on both formative and summative assessments as well as sign the

logbook and portfolio. The residents are made aware of their

limitations and are encouraged to seek advice and receive help at all

times. The Course Coordinator of each department coordinates all

training and academic activities of the program in collaboration with

the Course Director. The Course Director of each faculty directs

guides and manages curricular activities under his/ her jurisdiction

and is the person to be reported to for all events and performances of

the residents and the supervisors.

10. Curriculum Implementation, Review and Updating:

Both Supervisors and Residents are expected to have a good

knowledge of the curriculum and should use it as a guide for their

training program.

Since Pulmonology has historically been rapidly changing speciality

the need for review and up-dating of curriculum is evident. The


Curriculum is specifically designed to guide an educational process

and will continue to be the subject of active re-drafting, to reflect

changes in both pulmonology and educational theory and practice.

Residents and Supervisors are encouraged to discuss the curriculum

and to feedback on content and issue regarding implementation at

Residency Course Director. Review will be time tabled to occur

annually for any minor changes to the curriculum. The Curriculum will

be reviewed with input from the various subspecialties of

Pulmonology.

11. Phase B Syllabus:

The educational process in Respiratory Medicine aims to provide

basic knowledge, intellectual, clinical and transferable skills to

produce competent specialists in Pulmonology. These specialists will

be capable of providing specialized care of the highest order to

patients with respiratory disorders in the community as well as clinical

tertiary centres. They will recognize the health needs of the

community and carry out professional obligations ethically and

keeping their standards by engaging in continuing medical education.

The program also aims to introduce the candidate to the basics of

scientific medical research.

Module A.1: Structure and function of the respiratory system

A.1.1 Anatomy

A.1.2 Development and ageing of respiratory system

A.1.3 Physiology

A.1.4 Pathophysiology A.1.5 Microbiology A.1.6 Genetics

A.1.7 Pharmacology

A.1.8 Pathology

A.1.9 Immunology and defence mechanisms

A.1.10 Molecular biology

A.1.11 Biochemistry

Module B.1: Airway diseases

B.1.1 Asthma

B.1.2 Acute bronchitis

B.1.3 Chronic bronchitis

B.1.4 COPD (chronic bronchitis and/or emphysema)


B.1.5 Bronchiolitis

B.1.6 Bronchiectasis

B.1.7 Airway stenosis and malacia B.1.8 Trachea-oesophageal fistula

B.1.9 Upper airway disease

B.1.10 Vocal cord dysfunction

B.1.11 Foreign body aspiration

B .1.12 Gastro-oesophageal reflux

Module B.2: Thoracic tumours

8.2.1 Lung cancer

8.2.2 Metastatic pulmonary tumours

8.2.3 Mesothelioma

8.2.4 Metastatic and other pleural tumours

8.2.5 Benign intra-thoracic tumours

8.2.6 Mediastinal tumours B.2.7 Chest wall tumours B.2.8 Sarcoma

B.2.9 Lymphoma

Module B.3: Non-TB respiratory infections

B.3.1 Upper respiratory tract infections

B.3.2 Lower respiratory tract infections

B.3.3 Community-acquired pneumonia (CAP)

B.3.4 Nosocomial pneumonia

B.3.5 Pneumonia in the immunocompromised host

B.3.6 Other pneumonia

B.3.7 Parapneumonic effusion and empyema

B.3.8 Lung abscess B.3.9 Fungal infection B.3.10 Parasitic infection

B.3.11 Epidemic viral infection

Module B.4: Tuberculosis

B.4.1 Pulmonary TB

8.4.2 Extrapulmonary TB

B.4.3 TB in the immunocompromised host

8.4.4 Latent tuberculous infection

B.4.5 Non-tuberculous mycobacterial diseases

B.4.6 Tuberculosis and HIV


Module B.5: Pulmonary vascular diseases

B.5.1 Pulmonary embolism

B.5.2 Primary pulmonary hypertension

8.5.3 Secondary pulmonary hypertension

B.5.4 Vasculitis and diffuse pulmonary haemorrhage

B.5.5 Abnormal a-v communication

Module B.6: Occupational and environmental diseases

B.6.1 Occupational asthma

B.6.2 Reactive airway dysfunction syndrome (RADS)

B.6.3 Pneumoconiosis and asbestos-related disease

B.6.4 Hypersensitivity pneumonitis

B.6.5 Dust and toxic gas inhalation disease

B.6.6 Indoor pollution related disease

B.6.7 Outdoor pollution related disease

B.6.8 Smoking-related disease

B.6.9 High-altitude disease

B.6.10 Diving-related disease

Module B.7: Diffuse Parenchymal (interstitial) lung diseases (DPLD)

B.7.1 Sarcoidosis

B.7.2 Idiopathic interstitial pneumonias including idiopathic

pulmonary fibrosis (IPF). non-specific interstitial pneumonia

(NSI P), cryptogenic organising pneumonia (COP), acute

interstitial pneumonia (AIP), respiratory bronchiolitis- associated

interstitial lung disease (RB-ILD), desquamative interstitial

pneumonia (DIP), lymphoid interstitial pneumonia (LIP)

B.7.3 Cryptogenic organising pneumonia (COP) of unknown

aetiology/ bronchiolitis obliterans organising pneumonia (BOOP)

Module B.8: Iatrogenic diseases

B.8.1 Drug-induced disease

B.8.2 Complications of invasive procedures

B.8.3 Radiation-induced disease

Module B.9: Acute injury

B.9.1 Inhalation lung injury

B.9.2 Traumatic thoracic injury


Module B.10: Respiratory failure

B.10.1 Acute respiratory distress syndrome

B.10.2 Obstructive lung disease

B.10.3 Neuromuscular disease

B.10.4 Chest wall disease

B.10.5 Other restrictive diseases

Module B.11: Pleural diseases

B.11.1 Pleural effusion

B.11.2 Chylothorax

B.11.3 Haemothorax

B.11.4 Fibrothorax

B.11.5 Pneumothorax

Module B.12: Diseases of the chest wall and respiratory muscles

including the diaphragm

B.12.1 Chest wall deformities

B.12.2 Neuromuscular disorders

B.12.3 Phrenic nerve palsy

B.12.4 Diaphragmatic hernia

Module B.13: Mediastinal diseases excluding tumours

B.13.1 Mediastinitis

8.13.2 Mediastinal fibrosis

B.13.3 Pneumo-mediastinum

Module B.14: Pleuro-pulmonary manifestations of systemic/

extrapulmonary disorders

B.14.1 Collagen vascular disease

B.14.2 Cardiac disease

B.14.3 Abdominal disease

B.14.4 Haematological disease

B.14.5 Obesity

B.14.6. Hyperventilation syndrome

Module B.15: Genetic and developmental disorders

B.15.1 Cystic fibrosis

B.15.2 Primary ciliary dyskinesia

B.15.3 Alpha-1 antitrypsin deficiency

B.15.4 Malformations


Module B.16: Respiratory diseases and pregnancy

B.16.1 Asthma

B.16.2 Cystic fibrosis

B.16.3 Tuberculosis

B.16.4 Sarcoidosis

B.16.5 Restrictive lung diseases

B.16.6 Pregnancy-induced respiratory diseases

Module B.17: Allergic diseases (lgE•mediated)

B.17.1 Upper airway disease

B.17.2 Asthma

B.17.3 Bronchopulmonary aspergillosis

B.17.4 Anaphylaxis

Module B.18: Eosinophilic lung diseases

B.18.1 Non-asthmatic eosinophilic bronchitis

B.18.2 Acute and chronic eosinophilic pneumonia

B.18.3 Hyper-eosinophilic syndrome

B.22.3 Tuberculosis

8.22.4 Surfactant deficiency diseases

Module B.19: Sleep-related disorders

B.19.1 Obstructive sleep apnoea syndrome

B.19.2 Central sleep apnoea syndrome

B.19.3 Obesity hypoventilation syndrome

Module B.20: Immunodeficiency disorders

B.20.1 Congenital immunodeficiency syndrome

B.20.2 Acquired immunodeficiency syndrome

B.20.3 HIV-related disease

B.20.4 Drug-induced disease

B.20.5 Graft versus host disease

B.20.6 Post-transplantation immunodeficiency

Module B.21: Orphan lung diseases

B.21.1 Langerhans' cell histiocytosis

B.21.2 Lymphangioleiomyomatosis (LAM)

B.21.3 Pulmonary alveolar proteinosis

8.21.4 Amyloidosis


Module B.22: Paediatric pulmonology

B.22.1 Asthma

B.22.2 Respiratory tract infections (ARI)

B.22.3 Tuberculosis

B.22.4 Surfactant deficiency diseases

Module C.1: Symptoms and signs

C.1 .1 Dyspnoea

C.1 .2 Wheeze

C.1.3 Stridor

C.1.4 Hoarseness

C.1.5 Cough

C.1.6 Sputum production

C.1.7 Chest pain

C.1.8 Haemoptysis

C.1.9 General symptoms of disease including fever, weight loss,

oedema, nocturia, and daytime somnolence

C.1.10 Abnormal findings on inspection including cyanosis,

abnormal breathing patterns, finger clubbing, chest wall

deformities, superior vena cava syndrome and Homer's

syndrome

C.1.11 Abnormal findings on palpation and percussion

C.1.12 Abnormal findings on auscultation

Module D.1: Pulmonary function testing

D.1.1 Static and dynamic lung volumes- interpretation and performance

D.1.2 Body plethysmography- interpretation

D.1.3 Gas transfer- interpretation

D.1.4 Blood gas assessment and oximetry/capnography- interpretation

and performance

D.1.5 Bronchial provocation testing- interpretation and performance

0.1.6 Exercise testing including 6 MWT and spiro-ergometry

(cardio-pulmonary exercise testing)- interpretation and

performance

D.1. 7 Assessment of respiratory mechanics- interpretation

D.1.8 Compliance measurements- interpretation


D.1.9 Respiratory muscle assessment- interpretation

D.1.10 Ventilation-perfusion measurement- interpretation

D.1.11 Shunt measurement- interpretation

D.1.12 Sleep studies/POLYSOMNOGRAPHY- interpretation and

performance

D.1.13 Measurement of regulation of ventilation- interpretation

Module D.2: Other procedures

D.2.1 Blood tests and serology relevant to respiratory medicine

D.2.2 Analysis of exhaled breath components including NO, CO

and breath condensate

D.2.3 Sputum induction

D.2.4 Sputum analysis

D.2.5 Tuberculin skin testing

0.2.6 Allergy skin testing

D.2.7 Pleural ultrasound imaging

D.2.8 Thoracentesis

0.2.9 Closed pleural needle biopsy

D.2.10 Pleuroscopy (medical thoracoscopy)

D.2.11 Flexible bronchoscopy

0.2.12 Transbroncnial lung biopsy D.2.13 Transbronchiat needle

aspiration D.2.14 Endobronchial ultrasound

D.2.15 Broncho-alveolar lavage

D.2.16 Bronchography

0.2.17 Rigid bronchoscopy

0.2.18 lnterventional bronchoscopic techniques including fluorescence

bronchoscopy, brachytherapy, endobronchial radiotherapy,

afterloading laser and electrocoagulation cryotherapy,

photodynamic therapy, airway stents/thermoplasty

0.2.19 Percutaneous needle biopsy

D.2.20 Fine needle lymph node aspiration for cytology

D.2.21 Right heart catheterisation

D.2.22 Chest X-ray

D.2.23 Fluoroscopy


Module D.3: Procedures performed collaboratively

D.3.1 Thoracic imaging (X-ray, CT, MRI)

D.3.2 Nuclear medicine techniques (pulmonary and bone scan PET)

0.3.3 Electrocardiogram D.3.4 Echocardigram

D.3.5 Ultrasound

D.3.6 Transoesophageal ultrasound

D.3.7 Oesophageal pH monitoring

D.3.8 Cytology/histology

D.3.9 Microbiology testing

Module E.1: Treatment modalities and prevention measures

E.1.1 Systemic/inhaled drug therapy

E.1.2 Chemotherapy

E.1.3 Other systemic anti-tumour therapy

E.1.4 lmmunotherapy including de-/hyposensitisation

E.1 .5 Oxygen therapy

E.1.6 Ventilatory support (invasive/non-invasive/CPAP)

E.1.7 Cardiopulmonary resuscitation

E.1.8 Assessment for anaesthesialsurgery

E.1.9 Endobronchial therapies

E.1.10 lntercostal tube drainage

E.1.11 Pleurodesis

E.1.12 Home care

E.1.13 Palliative care

E.1.14 Pulmonary rehabilitation

E.1.15 Nutritional interventions

E.1.16 Surfactant therapy

E.1.17 Gene therapy

E.1. 18 Principles of stem cell therapy

E.1.19 Smoking cessation

E.1.20 Vaccination and infection control

E.1.21 Other preventative measures


Module F: Core generic abilities

F.1 Communication in~luding patient education and public awareness

F.2 Literature appraisal

F.3 Research

F.4 Teaching

F.5 Audit/quality assurance of clinical practice

F.6 Multidisciplinary teamwork

F.7 Administration and management

F.8 Ethics

Module G: Competence in fields shared with other specialties

G.1 Intensive care

G.2 High-dependency unit (HOU)

G.3 Critical Care Medicine (CCM)

Module H: Knowledge of associated fields relevant to adult

respiratory medicine

H.1 Thoracic surgery (including lung transplantation)

H.2 Radiotherapy

H.3 Chest physiotherapy

H.4 Other relevant medical specialties

Module I: Further areas relevant to respiratory medicine

1.1 Epidemiology

1 .2 Statistics

1.3 Evidence-based medicine

1.4 Quality of life measures

1.5 Psychological factors in the development of respiratory disease

1.6 Psychological consequences of chronic respiratory disease

1. 7 Public health issues

1.8 Organization of healthcare in Bangladesh (Healthcare delivery

system)

1.9 Economics of healthcare across the world

1.10 Compensation and legal issues in home & abroad


FCPS (Pulmonary & Thoracic Surgery)

This course is under supervision of Bangladesh College of Physicians

& Surgeons. But theses part student placed here for 2 years. Thesis

work also done here.

Library

The institute is equipped with a library for the teachers and students of

NIDCH. The library run by a librarian and an assistant. Library of the

institute is located in the 4th floor of the National Asthma Center (NAC)

building. It has a sitting capacity of about 100 students. The library is

fully air-conditioned. About 1500 books and a small number of

Journals are available in this library.

The library is open from 8 a.m. to 9 p.m. The library provides

photocopy facilities round the service hour. Broad band internet facility

is an special addition to this library.


COURSE CURRICULUM FOR THE MS (THORACIC SURGERY)

PART-A

• Anatomy

• Physiology, Biochemistry, Pharmacology

• Pathology, immunology, biostatistic

• General surgery

All mentioned in syllabus

PART-B

1. Thoracic Surgery (Syll: 1-30)

2. Operative Surgery (Chest)

3. Surgical Pathology (Chest Diseases)

4. Thoracic Anesthesiology (Principle)

5. Cardiac Surgery (Principle of open heart surgery- heart-lung mac)

6. Vascular Surgery (Aneurysm principle of repair)


SYLLABUS FOR THE MASTER OF SURGERY (THORACIC)

BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY (BSMMU)

PART – A

A. Anatomy:

1. Gross Anatomy & Regional Anatomy

a) General

b) Lungs, Bronchovascular Segment, Trachea,

Mediastinum, Pleura, Diaphragm, Thoracic cavity & chest

wall, oesophagous

c) Heart

d) Blood vessels & lymphatics

e) Gl tract (stomach, duodenum, small and large gut, liver,

spleen, pancreas, omentun, mesentry, portal system)

2. Developmental Anatomy of Respiratory Systen

3. Histology – of allied subject

4. Applied Anatomy – of allied subject

B. Physiology, Biochemistry & Pharmacology

a. Physiology :

1. General Principle of Physiology

2. Cardiovascular Physiology

a) Cardiac cycle

b) Heart muscle & its contractions

c) Conducting system and Electro-Physiology

d) Haemodynamics

3. Respiratory Physiology with Positive Pressure Ventilation

(Artificial ventilation)

a) Respiratory functions & tests

b) Positive Pressure Ventilation (Artificial ventilation)

c) Blood gases

d) Blood vessels & lymphatics

4. Physiology of Nervous System – specially cardio-resp.

innervation


b. Pharmacology :

1. General Pharmacology

a) Machanism of drug action

b) Drug interaction

c) Adverse reaction to drug

d) Principle of drug therapy

2. Pain killers

3. Chemotherapy & Antibiotics (Pharmacology of Respiratory

system in the surgical pain)

4. Diuretics

5. Drug working on Autonomic Nervous System

6. Anticoagulants

7. Bronchodilators & Mucolytic agtents

8. Steroid in Surgery

9. Vasodilators

10. Vitamin and Mineral

Biochemistry :

a) Cell & its function

b) Fluid & Electrolytes

c) Acid Base balance

d) Metrobolic response to trama

e) Nutrition in surgical patient

f) Parenteral Nutrition

g) Enzymes of clinical importance

c. Pathology & Microbiology :

a. Pathology :

1. General Pathology

a) Cellular degeneration & necrosis & oedema

b) Inflammation

c) Infarction

d) Thrombosis and Embolism

e) Athero Sclerosis

f) Haemorrhage & Shock

g) Aneurysm

h) Calcification

i) Neoplasm (tumour)

j) Infection


b. Microbiology :

1. Micro organism of surgical importance

2. Hospital infections

3. Investigation & Diagnosis of Microbial Disease

4. Prevention and Treatment of Microbial Diseases

5. Medical Genetics

D. Immunology :

E. Biostatistic

F. General Surgery

Basic Principles of General Surgery

a. Laparotomy, incision

b. Disease & Surgery of Liver

c. Surgery in Portal Hypertension

d. Diabetes & Surgery

e. Disease and Surgery of Stomach, Duodenum (small & large

gut)

f. Disease and Surgery of Spleen

g. Disease and Surgery of Breast

h. Incision & exploration of the neck

PART – B ( 3 Years)

1st Term : 6 months

o Statistics : Genetics, epidemiology class

o Ward Duty

o Research methodology

o Submit thesis protocol/original papers (at the end of 6

months)

Next 2 (two) years

o Residential clinical duty – Evaluation

o Lecture attend

o Clinical meetings

o Case Presentation, Clinical seminar

Next 2 (two) months

o Exposure to cardiac vascular surgery ( NICVD)



Next 4 (four) months

o Submit Thesis, Residential work

o Total Evaluation

Examination

o Theory : Written (100 marks)

- Paper I

- Paper II

o Practical : Long Viva (200 marks)

- Instrument

- X-ray

- Specimen

- Operative surgery

o Clinical (100 marks) : - Long case

- Short case

o Thesis - (200 marks)

Defence


SYLLABUS FOR MS (Thoracic Surgery)

PART – B

1. Thoracic Surgery – Surgical Pathology & Operative Surgery 75 hrs

Thoracic Surgery :

1. Endoscopy Bronchoscopy, Oesophagoscopy & Mediostinoscopy

2. Preoperative assessment of patient

3. Chest Radiology

4. Anesthesia for thoracic surgery

5. Shock & circulatory collapse

6. Post operative management

7. Thoracic incisions and surgical approches

8. Tracheostomy and assisted ventilations


9. Congenital lesions, neoplasms & injuries of trachea

10. Thoracic surgery in infants

11. Chest injury

12. Mediastinum & Mediastinum tumours

13. Lung infarctions

14. Non malignant tumours of lung

15. Cancer lung

16. Surgical treatment of pulmonary Tuberculosis

17. Congenital lessions of the lung & emphysema

18. Pulmonary enbolism

19. Surgical problems of the oesophagus in infants and children

20. Disorder of the oesophagus in adult

21. Oesophygal hiatus hernia

22. The diaphragm

23. Role of Radio therapy in the malignant diseases of chest

24. Role of Physiotherapy in Chest diseases and chest surgery

25. Foreign body in air passages and oesophagus

26. Role of Nuclear Medicine in Thoracic and Surgery

27. Diseases and surgery of the pleura, Chest wall

28. Computer for surgeons & surgical audit

29. Lung transplantation

30. Pulmonary hypertension

Affiliation

1. University of Dhaka

2. Bangladesh College of Physicians and Surgeons

3. Bangabandhu Sheikh Mujib Medical University (BSMMU)